Clinical Trial Update: Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating theophylline as treatment for pseudohypoparathyroidism in children aged 2-12; the study is currently active but not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Albright Hereditary Osteodystrophy
• Pseudohypoparathyroidism
• Pseudohypoparathyroidism Type 1a

Drugs mentioned

• Theophylline (Theophylline)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Pseudohypoparathyroidism, Albright Hereditary Osteodystrophy | Phase 2 | Status: ACTIVE_NOT_RECRUITING